nach oben

Sleep and Breathing

Erschienen in:

27.04.2022 | Sleep Breathing Physiology and Disorders • Original Article

The effect of continuous positive airway pressure treatment on inflammatory parameters and periostin levels in patients with obstructive sleep apnea syndrome

verfasst von: Fatma Tosun, Cenk Babayiğit, Nursel Dikmen, Serdar Doğan, Emre Dirican

Erschienen in: Sleep and Breathing | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of the study was to examine the effects of continuous positive airway pressure (CPAP) treatment on inflammation parameters in patients with obstructive sleep apnea syndrome (OSAS).

Methods

Patients aged 18 to 65 years who underwent polysomnography (PSG) in the sleep clinic between January 1, 2019, and December 31, 2019, were included in the study. Patients with severe OSAS initiated treatment with CPAP. Patients and control subjects were assessed for levels of periostin, TNF-alpha, TGF-beta, and IL-6. Patients were re-evaluated 3 months later. Comparisons for the serum markers were made between controls and patients of different severity of OSAS. Comparisons of serum markers were also made between baseline and 3 month follow-up.

Results

A total of 92 patients were enrolled in the study, including 25 controls (apnea-hypopnea index or AHI < 5/h), 39 patents with mild to moderate OSAS who did not receive CPAP, and 28 patients with severe OSAS receiving CPAP treatment. When all three groups were compared, levels of periostin, TNF-alpha, TGF-beta, and IL-6, as inflammatory markers, were higher in the OSAS group, though not at a statistically significant level. In patients with severe OSAS, there were statistically significant decreases in the TGF-beta 1, TNF-alpha, and IL-6 values between baseline values and the same measures taken after 3 months of CPAP treatment. Periostin values also decreased after treatment, but this decrease was not at a significant level.

Conclusion

Inflammatory parameters of patients with OSAS were significantly higher compared with healthy participants. Regression of inflammation was detected after CPAP treatment.

Gaines J, Vgontzas AN, Fernandez-Mendoza J et al (2018) Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev 42:211–219. https://doi.org/10.1016/j.smrv.2018.08.009CrossRefPubMedPubMedCentral

Dursunoğlu N, Dursunoğlu D (2005) Obstrüktif uyku apne hipopne sendromunun kardiyovasküler sistem üzerine etkileri [The effects of obstructive sleep apnea hypopnea syndrome on cardiovascular system]. Anadolu Kardiyol Derg. 5(1):41–45 (Turkish)PubMed

Wolk R, Somers VK (2006) Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 8(3):250–260. https://doi.org/10.1111/j.1463-1326.2005.00508.xCrossRefPubMed

Meier-Ewert HK, Ridker PM, Rifai N et al (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43(4):678–683. https://doi.org/10.1016/j.jacc.2003.07.050CrossRefPubMed

Masuoka M, Shiraishi H, Ohta S et al (2012) Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 122(7):2590–2600. https://doi.org/10.1172/JCI58978CrossRefPubMedPubMedCentral

Izuhara K, Nunomura S, Nanri Y, Ono J, Takai M, Kawaguchi A (2019) Periostin: an emerging biomarker for allergic diseases. Allergy 74:2116–2128CrossRefPubMed

Kimura H, Konno S, Makita H, Taniguchi N, Kimura H, Goudarzi H, Shimizu K, Suzuki M, Shijubo N, Shigehara K, Ono J, Izuhara K, Ito YM, Nishimura M (2018) Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int 67(3):357–363. https://doi.org/10.1016/j.alit.2017.11.006CrossRefPubMed

Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Holweg C, Itoh K, Inoue H, Hashimoto S (2019) Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol Pract 7(1):134-145.e1. https://doi.org/10.1016/j.jaip.2018.06.015CrossRefPubMed

Zhang Z, Nie F, Kang C, Chen B, Qin Z, Ma J, Ma Y, Zhao X (2014) Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions. Int J Mol Med 34(1):253–261. https://doi.org/10.3892/ijmm.2014.1760CrossRefPubMed

10.

Çayakar A (2018) What is tumor necrosis factor alpha ? Turkiye Klinikleri J Intern Med 3(2):67–76. https://doi.org/10.5336/intermed.2018-61424CrossRef

11.

Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation immunity and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295CrossRefPubMedPubMedCentral

12.

Nagayoshi M, Yamagishi K, Tanigawa T et al (2011) Risk factors for snoring among Japanese men and women: a community-based cross-sectional study. Sleep Breath 15(1):63–69. https://doi.org/10.1007/s11325-009-0319-6CrossRefPubMed

13.

Young T, Peppard PE, Taheri S (2005) Excess weight and sleep-disordered breathing. J Appl Physiol (1985) 99(4):1592–1599CrossRefPubMed

14.

Kandasamy G, Almaghaslah D, Sivanandy P et al (2019) Effectiveness of nasal continuous airway pressure TREATMENT in patients with obstructive sleep apnea. Int J Health Plann Manage 34(2):e1200–e1207. https://doi.org/10.1002/hpm.2758CrossRefPubMed

15.

Ding X, Yu C, Liu Y et al (2016) Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling in a canine model. Oncotarget 7(36):57545–57555CrossRefPubMedPubMedCentral

16.

McNicholas WT (2009) Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 51(5):392–399. https://doi.org/10.1016/j.pcad.2008.10.005CrossRefPubMed

17.

Walsh JA, Duffin KC, Crim J et al (2012) Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors. J Clin Sleep Med 8(6):643–648. https://doi.org/10.5664/jcsm.2254CrossRefPubMedPubMedCentral

18.

Ifergane G, Ovanyan A, Toledano R et al (2016) Obstructive sleep apnea in acute stroke: a role for systemic inflammation. Stroke 47(5):1207–1212. https://doi.org/10.1161/STROKEAHA.115.011749CrossRefPubMed

19.

Thunström E, Glantz H, Fu M et al (2015) Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea. Sleep 38(3):463–471. https://doi.org/10.5665/sleep.4510CrossRefPubMedPubMedCentral

20.

Leon-Cabrera S, Arana-Lechuga Y, Esqueda-León E et al (2015) Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators Inflamm 2015:493409. https://doi.org/10.1155/2015/493409CrossRefPubMedPubMedCentral

21.

Li Q, Zheng X (2017) Tumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome a meta analysis. Oncotarget 8(16):27616–27626. https://doi.org/10.18632/oncotarget.15203CrossRefPubMedPubMedCentral

22.

Clark DA, Coker R (1998) Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 30(3):293–298. https://doi.org/10.1016/s1357-2725(97)00128-3CrossRefPubMed

23.

Ding WX, Dong YB, Ding N et al (2014) Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway. J Thorac Dis 6(9):1278–1284. https://doi.org/10.3978/j.issn.2072-1439.2014.07.44CrossRefPubMedPubMedCentral

24.

Steffanina A, Proietti L, Antonaglia C et al (2015) The plasminogen system and transforming growth factor-β in subjects with obstructive sleep apnea syndrome: effects of CPAP treatment. Respir Care 60(11):1643–1651. https://doi.org/10.4187/respcare.03571CrossRefPubMed

25.

Alberti A, Sarchielli P, Gallinella E et al (2003) Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12(4):305–311. https://doi.org/10.1111/j.1365-2869.2003.00361.xCrossRefPubMed

26.

Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295CrossRefPubMedPubMedCentral

27.

Li Y, Vgontzas AN, Fernandez-Mendoza J, et al (2017) Objective, but not subjective, sleepiness is associated with inflammation in sleep apnea. Sleep 40 https://doi.org/10.1093/sleep/zsw033.

28.

Huang YS, Guilleminault C, Hwang FM et al (2016) Inflammatory cytokines in pediatric obstructive sleep apnea. Medicine (Baltimore) 95:e4944. https://doi.org/10.1097/MD.0000000000004944CrossRefPubMed

29.

Kaditis AG, Gozal D, Khalyfa A et al (2014) Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations. Sleep Med 15:228–235. https://doi.org/10.1016/j.sleep.2013.08.795CrossRefPubMed

30.

Sunadome H, Matsumoto H, Tachikawa R et al (2020) Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study. Respir Res 21(1):143. https://doi.org/10.1186/s12931-020-01413-0CrossRefPubMedPubMedCentral

31.

Ji L, Liu Y, Liu P, Ji G, He J, Gan Y, Zhu S, Chen B, Zhang W (2021) Serum periostin and TNF-α levels in patients with obstructive sleep apnea-hypopnea syndrome. Sleep and Breathing 25:331–337. https://doi.org/10.1007/s11325-020-02124-yCrossRefPubMed

32.

Izuhara K, Nunomura S, Nanri Y et al (2017) Periostin in inflammation and allergy. Cell Mol Life Sci 74(23):4293–4303. https://doi.org/10.1007/s00018-017-2648-0CrossRefPubMed

33.

Kent BD, Ryan S, McNicholas WT (2011) Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178(3):475–481. https://doi.org/10.1016/j.resp.2011.03.015CrossRefPubMed

34.

Karamanli H, Özol D, Ugur KS et al (2014) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 18(2):251–256. https://doi.org/10.1007/s11325-012-0761-8CrossRefPubMed

35.

Steiropoulos P, Kotsianidis I, Nena E et al (2009) Long-term effect of continuous positive airway pressure TREATMENT on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 32(4):537–543. https://doi.org/10.1093/sleep/32.4.537CrossRefPubMedPubMedCentral

36.

Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134. https://doi.org/10.1161/01.cir.0000052627.99976.18CrossRefPubMed

37.

Guasti L, Marino F, Cosentino M et al (2011) Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. Sleep Breath 15(1):3–11. https://doi.org/10.1007/s11325-009-0315-xCrossRefPubMed

Titel: The effect of continuous positive airway pressure treatment on inflammatory parameters and periostin levels in patients with obstructive sleep apnea syndrome
verfasst von: Fatma Tosun
Cenk Babayiğit
Nursel Dikmen
Serdar Doğan
Emre Dirican
Publikationsdatum: 27.04.2022
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 1/2023
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-022-02616-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The effect of continuous positive airway pressure treatment on inflammatory parameters and periostin levels in patients with obstructive sleep apnea syndrome